Olaris Company

Olaris is on a mission to revolutionize how diseases are diagnosed and treated through the combination of metabolomics and machine learning

Last Funding Type: Series B
Funding Status: Early Stage Venture
Headquarters: Framingham, Massachusetts, United States
Founded Date: 2013-06-01
Last Funding Date: 2021-09-23
Technology: Biopharma, Biotechnology, Health Care
Employee Number: 1-10
Estimated Revenue: $1M to $10M
Investors Number: 3.0
Industry: Early Drug Development